Page 35 - Sohini Das

From budget to luxury, cars to get more expensive from January 2024

Maruti, Tata, M&M, Audi cite cost pressure for pushing up prices

Audi India raises prices of vehicles by 2% from Jan 1 on rising input costs

Audi India registered an 88 per cent growth and has retailed 5,530 units in the first nine months of this year

Pharma majors turn attention to OTC drugs in post-pandemic wellness shift

Building a healthy OTC brand, however, is not an easy task. OTC brands need time to grow and build a recall value once they have established some credibility

M&M Q2FY24 results: Profit hits brakes; consolidated net down 15%

On a sequential basis, the company's net profit declined 33 per cent from Rs 3,508 crore in the previous quarter, while it posted a 1.6 per cent rise in revenue from operations

PV wholesales touch all-time high for October even as car sales dip

The growth of the Passenger Vehicle (PV) segment is coming from the utility vehicles which clocked a Y-o-Y growth of 40 per cent to 198,356 units in October

Apollo Hospitals Q2 profit up 14% to Rs 4,846.9 cr on better patient flows

Apollo looking for another Greenfield hospital in Mumbai is not reported

Lupin's net profit jumps nearly four-fold on strong US growth, stock up

US sales cross $200 million for the first time in two years, beat analyst expectations

Eris to buy derma, nephro units of Biocon Biologics for Rs 366 cr

The agreement is for more than 20 brands that earned Rs 90 crore as revenue in FY23 and have a run rate of around Rs 100 crore

Automobile dealers flag 'distress' if Diwali sales fail to dazzle

The country's largest passenger car maker Maruti Suzuki India (MSIL) agreed that inventory levels are inching up in some models

Should touch Rs 1K crore from OTC this year, says Nandini Piramal

In an interview with Sohini Das, Piramal Pharma Chairperson Nandini Piramal outlines her plans, and why she wants to focus on profitability

How declining demand for natural diamonds is changing the dynamics of Surat

Lab diamonds are new sparklers on the block

Domestic tractor sales likely to pick up in the second half of 2023-24

Rating agency ICRA pointed out that the domestic tractor industry volumes remained healthy and represented a 12 percent YoY growth in FY2023, touching an all-time high of 9.45 lakh units

Blackstone makes health care foray with $1 bn deals, buys Care Hospitals

QCIL has signed a definitive agreement to acquire around 80 per cent in KimsHealth

Blurry skyline: Businesses hold their breath in Mumbai's smog-choked skies

With project execution and commercial office operations unaffected, city hopes for its air troubles to blow over

Cipla Q2 results: Profit surges 43% to Rs 1,131 crore on strong US sales

Cipla beat Bloomberg estimates which had pegged revenues at around Rs 6,490 crore and net income at Rs 984 crore

Dr Reddy's Laboratories Q2 results: Net profit rises 33% to Rs 1,480 crore

The company said that the Ebitda was enabled by geographic diversification and productivity improvement in operations

Practo aims to turn profitable in FY24, targets 50% revenue growth

Practo's co-founder and chief executive officer Shashank ND said that they have been focusing on profitability and so far in FY24, they have been cash flow positive

Want to eliminate lung cancer as a cause of death: AstraZeneca India MD

The British drug major is developing next-generation vaccines that have the potential to generate potent and long-lasting immune responses

Driving the change: Luxury car buyer is getting younger in India

Around 59 per cent of BMW buyers (in the luxury class) are aged between 31 and 45 years, and 35 per cent of its buyers are existing customers

Without whole-genome sequencing, a treatable TB epidemic is a challenge

HaystackAnalytics, an IIT Bombay-incubated company working in the area of genomics using big data has created a comprehensive drug resistance test for tuberculosis (TB)